(60%-89%), 90% (56%-100%), and 71% (48%-89%) for active myocarditis, respectively. Conclusions-T2 mapping seems to be superior when compared with standard CMR parameters, global myocardial T1, and extracellular volume fraction values for assessing the activity of myocarditis in patients with recent-onset heart failure and reduced left ventricular function. (Circ Cardiovasc Imaging. 2015;8:e003073.
P atients with myocarditis can be categorized by clinical presentation into 3 groups: the first group presents with acute chest pain, mimicking acute coronary syndrome, the second group presents with arrhythmia, and the third group with recent-onset heart failure. 1, 2 Patients of the latter group typically have severely reduced left ventricular (LV) function related to diffuse myocardial injury. 2 These patients are of particular interest because they may benefit from specific therapeutic interventions such as immunosuppressant agents in addition to standard therapy of HF. 3 
See Clinical Perspective
The clinical problem is that patients with HF because of active myocarditis and patients with more chronic stages of myocarditis without ongoing myocardial inflammation or even idiopathic dilated cardiomyopathy may have similar symptoms, levels of necrosis biomarkers, and echocardiographic findings. 1 Furthermore, the duration of symptoms does not allow reliable conclusions on disease activity on endomyocardial biopsy (EMB). 3, 4 EMB is therefore currently required in patients presenting with HF and reduced LV function to identify patients who have active myocardial inflammation. 3 Cardiac MRI (CMR) is currently the noninvasive method of choice to study patients with suspected myocarditis. 5 However, the accuracy of standard Lake-Louise CMR criteria for myocarditis is unsatisfactory in patients with recent-onset HF, which is most likely related to more chronic stages and more diffuse patterns of myocardial injury compared with patients Background-This study evaluated the performance of novel quantitative T1 and T2 mapping cardiovascular magnetic resonance (CMR) techniques to identify active myocarditis in patients with recent-onset heart failure. Methods and Results-Thirty-one consecutive patients with recent-onset heart failure, reduced left ventricular function and clinically suspected myocarditis underwent endomyocardial biopsy and CMR at 1.5 Tesla. The CMR protocol included standard Lake-Louise parameters as well as T1 mapping using a modified Look-Locker inversion recovery sequence and T2 mapping using a hybrid gradient and spin-echo sequence. Short-axis maps were generated using an OsiriX plug-in to calculate global myocardial T1, T2, and extracellular volume fraction. Active myocarditis was defined by ongoing inflammation on endomyocardial biopsy. T1 and T2 mapping CMR are novel techniques for quantitative tissue characterization, which may overcome the limitations of current CMR criteria to assess diffuse myocardial injury. [6] [7] [8] [9] [10] [11] [12] Recent studies indicate that native myocardial T1, myocardial T2, and extracellular volume (ECV) imaging could improve the diagnostic performance of CMR. 10, 12, 13 However, it is currently unclear whether these novel CMR techniques have the ability to differentiate active myocarditis from myocarditis without ongoing inflammation in patients presenting with recent-onset HF. Thus, this study evaluated the performance of T1 and T2 mapping CMR to identify patients with biopsy-proven active myocarditis in patients presenting with recent-onset HF and reduced LV function.
Methods

Patient Population
The local ethics committee approved the study. All patients and control subjects gave their written informed consent. Thirty-one consecutive patients were included between March 2013 and July 2014 who met the following criteria: (1) presentation with recent-onset HF, (2) LV ejection fraction of <45% in the absence of significant coronary artery disease, and (3) clinically indicated EMB and CMR.
14 This study did not include patients presenting acute coronary syndromelike or with arrhythmia, in whom EMB is not routinely performed in our institution. The median interval between onset of symptoms and presentation to our institution for diagnostic evaluation was 31 days with first (Q1) and third quartiles (Q3) of 6 and 64 days, respectively. The median interval between presentation and CMR was 3 days (Q1-Q3, 1-6 days), whereas the median interval between presentation and EMB was 10 days (Q1-Q3, 5-14 days). The major clinical characteristics of patients are presented in Table 1 .
Endomyocardial Biopsy
In agreement with current recommendations, at least 4 biopsies 1 to 2 mm in size were obtained from the left (n=12; 39%) or right ventricle (n=19; 61%). 1 Active myocarditis with ongoing myocardial inflammation was defined by ≥14 infiltrating leukocytes/mm 2 , CD3 + and CD68
+ macrophages in the presence of myocyte damage and fibrosis as described before. [15] [16] [17] [18] DNA and RNA were extracted and polymerase chain reaction/reverse transcriptase-polymerase chain reaction was performed to detect typical viruses in the samples as appropriate. [15] [16] [17] [18] A detailed description of the sample analysis is provided in the Data Supplement.
CMR Protocol
CMR was performed on a 1.5-T scanner (Achieva, Philips Medical Systems, Best, The Netherlands). The CMR protocol included standard steady-state free-precession cine CMR, black-blood T2-weighted short tau inversion recovery edema CMR, T1-weighted spin-echo early gadolinium enhancement CMR, and phase-sensitive inversion recovery late gadolinium enhancement CMR as described before. 13 A dose of 0.075 mmol/kg gadobenate dimeglumine contrastmedia was injected. T1-mapping was performed using a modified Look-Locker inversion recovery (MOLLI) sequence with a 3(3)5 scheme on 3 representative short-axis positions before and 15 minutes after contrast-media administration. T2-mapping was performed on 3 corresponding LV short axes using a black-blood prepared, navigator-gated, free-breathing hybrid gradient (echo planar imaging) and spin-echo multiecho sequence. 19 A detailed description of the CMR protocol is provided in the Data Supplement.
CMR Data Analysis
Global myocardial inflammation was assessed on T2-weighted images by calculating the T2 signal intensity ratio as signal intensity of myocardium divided by signal intensity skeletal muscle. 20 Global relative enhancement was calculated by measuring myocardial signal intensity on pre-and postcontrast T1-weighted spin-echo images relative to skeletal muscle. 5, 21 The presence and pattern of nonischemic LGE lesions were qualitatively assessed by consensus agreement of 2 experienced observers. Native and postcontrast T1, ECV, and T2 maps were generated using dedicated plug-ins written for the OsiriX software as described before. 13 Global native/postcontrast myocardial T1, ECV, and T2 values were calculated as the mean value of 3 shortaxes slices. A detailed description of CMR data analysis is provided in the Data Supplement.
Validation of T1 and T2 Measurements
The accuracy of the T1 and T2 mapping methods was evaluated by a relaxometry study in a Eurospin Gel-Phantom (TO5, Diagnostic Sonar LTD, Livingston, Scotland): the comparison of T1 values obtained by the MOLLI 3(3)5 and a reference scan has been previously reported.
13 T2 values obtained by the black-blood-prepared multiecho hybrid gradient and spin-echo sequence were compared with a spin-echo reference sequence with 16 echoes, 8-ms echo spacing, and 10-second time to repetition. Furthermore, myocardial T2 values were measured in 16 myocardial segments in an additional control group to assess reproducibility and regional variations of estimated myocardial T2. 22 This control group consisted of 11 healthy subjects (median age, 25 years [Q1-Q3, 24-28 years]) without symptoms or a history of any cardiovascular disease. In addition, interscan reproducibility was assessed for myocardial T1 and for T2 measurements by performing 10 repeated scans with identical imaging parameters. The interobserver reproducibility of data analysis was assessed between 2 blinded observers in all subjects.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, CA) and MedCalc for Windows, version 13.3.3.0 (MedCalc Software, Ostend, Belgium). Continuous data are presented as median with first and third quartiles (Q1-Q3). Categorical data are presented as numbers and percentage. Agreements were assessed between different measurements and observers by calculating the Bland-Altman mean bias and the coefficient of variation. Continuous data were compared using the nonparametric Mann-Whitney and Kruskal-Wallis test. Categorical data were compared using Fisher exact test. Two-sided P values were calculated and statistical significance was defined as P<0.05. There were no adjustments for multiple testing. A receiver-operating characteristic analysis was performed to calculate areas under the curves and the Youeden Index was used to depict optimal cutoff values from the receiver-operating characteristic curves. Sensitivities, specificities, accuracy, positive predictive values, and negative predictive values were calculated with 95% confidence intervals using the modified Wald method.
Results
Validation of T1 and T2 Measurements
Our group has recently reported a mean bias of 2%±7% compared with a reference scan in a phantom study and an interscan coefficient of variation of 0.7% for T1 measurements in healthy controls by the MOLLI 3(3)5 variant. 13 In this study, we found a mean bias of 3%±2% in T2 values by the hybrid gradient and spin-echo sequence compared with the reference scan. The mean interobserver difference and the interscan coefficient of variation were 1%±3% and 3.3% for global myocardial T2 values, respectively. In healthy subjects, median myocardial T2 was 55 ms (Q1-Q3, 54-57 ms) with a range of myocardial T2 values per segment between 43 and 63 ms. There were no significant regional differences in T2 values between the 
Activity of Myocarditis
EMB revealed active myocarditis with ongoing inflammation in 16 (52%) patients. There were no significant differences in the major clinical characteristics between patients with and without active myocarditis (Table 1) . Furthermore, the rate of active myocarditis was similar in patients who presented ≤4 weeks after onset of symptoms compared with patients who presented >4 weeks after onset of symptoms (8/15 versus 8/16; P=1.0000). A more detailed comparison of clinical and CMR parameters between patients with a presentation ≤4 weeks and >4 weeks after onset of symptoms is provided in the Table in the Data Supplement.
Conventional "Lake-Louise" CMR parameters Table 2 demonstrates CMR parameters in patients with and without active myocarditis. There were no significant differences in single or combined standard Lake-Louise criteria between patients with and without active myocarditis (Table 2) . No significant areas under the curves were found for T2-weighted CMR (0.56; P=0.5666), global relative enhancement (0.55; P=0.6819), and LGE (0.60; P=0.3428) to differentiate between patients with and without active myocarditis. Figure 1 demonstrates typical findings on T2-weighted short tau inversion recovery and LGE images in a patient with recent-onset systolic HF who had active myocarditis on EMB (Figure 1 ).
T1 Mapping/ ECV Imaging
There were no significant differences in global myocardial T1 and ECV values between patients with and without active myocarditis (Table 2) . Furthermore, the areas under the curves were not significant for native global myocardial T1 (0.65; P=0.1606), postcontrast global myocardial T1 (0.68; P=0.0969), and global myocardial ECV, 0.58; P=0.4646). Figure 1 demonstrates typical findings on native/postcontrast T1 and ECV maps in a patient with recent-onset HF who had active myocarditis on EMB (Figure 1 ). Figure 2) . A significant area under the curve of 0.78 (P=0.0091) was found for global myocardial T2 measurements to discriminate between patients with and without active myocarditis (Figure 3 ). The optimal cutoff value for global myocardial T2 was ≥60 ms, which provided a sensitivity of 94% (70%-100%), a specificity of 60% (32%-84%), an accuracy of 77% (60%-89%), a negative predictive value of 90% (56%-100%), and a positive predictive value of 71% (48%-89%) to differentiate between patients with and without active myocarditis. Figure 1 demonstrates a typical example for a T2 map in a patient with recentonset systolic HF who had an increased global myocardial T2 and active myocarditis on EMB (Figure 1 ).
T2 Mapping
Discussion
This study evaluated the diagnostic performance of standard and novel mapping CMR parameters to assess biopsy-proven active myocarditis in patients with recent onset of HF. The major findings were as follows: First, neither clinical characteristics, standard Lake-Louise parameters, global myocardial T1 nor ECV was able to differentiate between patients with and without active myocarditis. Second, global myocardial T2 was the only parameter with a significant difference between patients with and without active myocarditis. Third, a global myocardial T2 threshold of ≥60 ms provided a high sensitivity but modest specificity for identifying patients with active myocarditis.
Clinical Parameters
We did not find significant differences in clinical characteristics such as the duration of symptoms before presentation, Troponin T, and NT-proBNP levels between patients with and without active myocarditis (Table 1) . Furthermore, the rate of active myocarditis was similar in patients who presented ≤4 weeks after onset of symptoms compared with patients who presented >4 weeks after onset of symptoms. These findings illustrate the typical clinical problem that patients with active myocarditis, myocarditis without ongoing myocardial inflammation, and idiopathic dilated cardiomyopathy can present with similar clinical histories, laboratory findings, and echocardiograms. Our findings highlight that a reliable clinical discrimination of different stages of myocarditis is impossible in patients who present with recent-onset HF and reduced LV function. LGE, late gadolinium enhancement; and T2w ratio, signal intensity ratio of myocardium to skeletal muscle on T2-weighted cardiac magnetic resonance. T1 and T2 Mapping to Detect Active Myocarditis
Conventional Lake-Louise CMR Parameters
We did not find significant differences in either single or combined 2 of 3 Lake-Louise criteria between patients with and without active myocarditis (Table 2 ). This finding highlights recent findings by Lurz et al, 4 who showed that the diagnostic accuracy of Lake-Louise criteria is low in patients presenting with symptoms lasting >2 weeks, which is typical for patients with recent-onset HF. Furthermore, Francone et al 2 have recently reported a low sensitivity of current CMR criteria for patients similar to our study population with active myocarditis and recent-onset HF. However, the rate of LakeLouise-positive patients with active myocarditis was higher in our study with 14 of 16 (88%) patients than in the study by Francone et al, 2 who found 12 of 21 (57%) patients to be Lake-Louise positive in a similar population with HF and active myocarditis. This finding could be related to a lower prevalence of LGE in the study by Francone et al (12 of 21 [57%]) when compared with 12 of 16 (75%) in our study. 2 The different rates of LGE could be related to technical differences such as the use of a phase-sensitive inversion recovery sequence and qualitative data analysis in our study when compared with the study by Francone et al, who used a magnitude inversion recovery sequence and a semiquantitative data analysis. 2 Nevertheless, our findings are essentially in line with recent data on the limited diagnostic value of CMR in patients presenting with recent-onset HF.
2,4
T1 Mapping/ECV Imaging
Interestingly, we found similarly increased native myocardial T1 and ECV values in patients with and without active myocarditis (Table 2) . At first glance, this finding seems to contradict previous findings from Ferreira et al 10 and from our group 13 : Ferreira et al demonstrated an excellent diagnostic accuracy for native T1 maps in suspected acute myocarditis with acute chest pain compared with healthy controls. 10 We found that a combination of LGE with ECV imaging significantly improved the accuracy of CMR to differentiate patients with myocarditis from healthy controls. 13 Thus, native myocardial T1 and ECV imaging are obviously strong discriminators between diseased patients with myocarditis and healthy individuals, irrespective of the stage of the disease because of their sensitivity for several tissue alterations including edema, necrosis, and fibrosis. In contrast, both parameters could inherently be less specific for active myocardial inflammation because ECV and, to a lesser degree, native T1 values are also increased in chronic injury with myocardial fibrosis. 6, 23 Thus, the increased native myocardial T1 and ECV values in both groups of our study population could be related to edema and necrosis in the active myocarditis group as well as to myocardial fibrosis without ongoing inflammation in the other group (Table 2) . Notwithstanding, native myocardial T1 and ECV seem to be valuable instruments to differentiate between healthy individuals and diseased patients with myocarditis, irrespective of the stage of the disease.
4,13
T2 Mapping
Assessing myocardial T2 values in suspected myocardial inflammation has the principle advantage over T1-based techniques that myocardial T2 values closely correlate with free tissue water content, whereas the association between myocardial T1 and free tissue water content is significantly weaker. 24 In agreement with this theoretical consideration, global myocardial T2 was the only CMR parameter with a significant difference between patients with and without active myocarditis in our study (Table 2; Figure 2 ). The validity of our T2 quantification technique is supported by the phantom study and by the agreement of myocardial T2 values of healthy controls in our institution with external reference values in the literature. 11, 13 Furthermore, patients with active myocarditis in our study had similar global myocardial T2 values compared with myocardial segments with inflammation in a recent study by Thavendiranathan et al. 12 Thus, the excellent sensitivity and negative predictive value for active myocarditis in our study suggest that the probability of active myocarditis on EMB is low in patients who present with recent-onset HF and who have global myocardial T2 values <60 ms (Table 2; Figure 2 ). The plausibility of this cutoff value is supported by a similar cutoff value of ≥59 ms to differentiate involved from remote myocardial segments in the study by Thavendiranathan et al. 12 However, the modest specificity of 60% for active myocarditis in our study indicates that further evaluation by EMB is required in patients who have increased global myocardial T2 values (Table 2; Figure 2 ). Interestingly, Thavendiranathan et al 12 reported a high specificity of 97% to identify involved myocardial segments by increased T2 values in patients with myocarditis or Tako-Tsubo cardiomyopathy, respectively. However, several differences in study design may explain this discrepancy: First, Thavendiranathan et al compared regional CMR characteristics between involved and remote myocardial segments, whereas we evaluated global differences in CMR characteristics between patients with and without active myocarditis. 12 Second, patients in the study by Thavendiranathan et al had mildly reduced LV ejection fractions (mean, 50%±9%), which is typical for patients with infarct-like patterns compared with patients with HF and severely reduced LV ejection fractions (median, 30% [Q1-Q3, 19%-35%]) in our study. 2, 12 Thus, the study population of Thavendiranathan et al addressed patients with focal patterns of myocardial injury, whereas our patients with HF had more diffuse myocardial injury. Third, Thavendiranathan et al defined involved myocardium by visual analysis of cine CMR and LGE images, whereas we used EMB as reference technique. 12 However, the agreement in absolute T2 values of involved myocardial segments in the study by Thavendiranathan et al with global myocardial T2 values in our study population highlights the capability of T2 mapping to depict both focal and also diffuse patterns of myocardial inflammation. 12 Thus, T2 mapping could potentially be used to preselect patients with recentonset HF for EMB in terms of skipping EMB in patients with a low probability of active myocarditis. Nevertheless, further evaluation of this hypothesis is required to determine siteindependent thresholds for global myocardial T2 before clinical implementation of T2 mapping CMR as a gatekeeper for EMB in suspected myocarditis.
Limitations
A larger study population could have led to significant differences in native myocardial T1 between patients with and without active myocarditis (Table 2) . Furthermore, the performance of T1 mapping in this study could have been hampered by the sensitivity of the 3(3)5 MOLLI variant for heart rate with lower T1 values at higher heart rates. 25 Using a different T1 mapping sequences with less heart-rate sensitivity, such as the 5(3s)3 MOLLI variant, could have resulted in an improved performance of native T1 mapping in our study population. 25 Technical differences in the CMR protocol compared with recent studies such as a different slice thickness or the use of gadobenate dimeglumine instead of gadopentetate dimeglumine could have confounded the rate of Lake-Louise-positive patients in this study. 5 This study focused on global myocardial injury because myocardial injury is predominantly diffuse in patients with myocarditis and recent-onset HF. 2 However, applying a threshold technique to T1, ECV, and T2 maps could provide incremental information on focal myocardial injury and will be an interesting additional target for a future study. A general limitation of EMB is the potential sampling error. We obtained at least 4 samples from the left or right ventricle as a part of clinical routine in agreement with current recommendations. 1 Previous studies indicated that obtaining 5 to 6 samples could minimize the sampling error, 4, 16 but there is no consensus on the optimal number of samples to date.
Conclusions
T2 mapping seems to be superior when compared with standard CMR parameters, global myocardial T1, and ECV values for assessing the activity of myocarditis in patients with recent-onset HF and reduced LV function.
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